Intravenous treatment with liposome-encapsulated dichloromethylene bisphosphonate (Cl2MBP) suppresses nitric oxide production and reduces genetic resistance to Marek's disease.

C Rivas; A Djeraba; E Musset; N. van Rooijen; B Baaten; P Quere

doi:10.1080/030794502100007163

Intravenous treatment with liposome-encapsulated dichloromethylene bisphosphonate (Cl2MBP) suppresses nitric oxide production and reduces genetic resistance to Marek's disease.

C Rivas, A Djeraba, E Musset, N. van Rooijen, B Baaten, P Quere

VU University medical center

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	139-149
Journal	Avian Pathology
Volume	32
Issue number	2
DOIs	https://doi.org/10.1080/030794502100007163
Publication status	Published - 2003

Access to Document

10.1080/030794502100007163

Embargoed Document

165603
Final published version, 1.07 MB

Cite this

@article{91080ae04d094eeb9e2c91033f36239c,

title = "Intravenous treatment with liposome-encapsulated dichloromethylene bisphosphonate (Cl2MBP) suppresses nitric oxide production and reduces genetic resistance to Marek's disease.",

author = "C Rivas and A Djeraba and E Musset and {van Rooijen}, N. and B Baaten and P Quere",

year = "2003",

doi = "10.1080/030794502100007163",

language = "English",

volume = "32",

pages = "139--149",

journal = "Avian Pathology",

issn = "0307-9457",

publisher = "Taylor and Francis Ltd.",

number = "2",

}

TY - JOUR

T1 - Intravenous treatment with liposome-encapsulated dichloromethylene bisphosphonate (Cl2MBP) suppresses nitric oxide production and reduces genetic resistance to Marek's disease.

AU - Rivas, C

AU - Djeraba, A

AU - Musset, E

AU - van Rooijen, N.

AU - Baaten, B

AU - Quere, P

PY - 2003

Y1 - 2003

U2 - 10.1080/030794502100007163

DO - 10.1080/030794502100007163

M3 - Article

VL - 32

SP - 139

EP - 149

JO - Avian Pathology

JF - Avian Pathology

SN - 0307-9457

IS - 2

ER -